Clark, H. D., Knisely, A., Villanueva, A., Lito, K., Bazan-Peregrino, M., Owen, H., Nutbrown, R., Bridger, H., Saggese, M., Apelian, D., Duffy, M., Jazaeri, A. A. (2026). A phase I, open-label, dose-finding, safety, tolerability, and exploratory trial of intraperitoneal THEO-260 in patients with high-grade serous or endometrioid ovarian cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps5635